AzTrials
AzTrials

NeuropsychologyPSKNCT07883096

Parsing the Impact of Calories Versus Sweet Taste on Beverage Brand Conditioning

A study testing 3-week daily beverage intervention in people with Neuropsychology and Ingestive Behavior, run by Monell Chemical Senses Center.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

The purpose of this study is to learn how the sweet taste and the calorie content of a beverage affect the way people respond to the brand logo printed on that beverage. Previous work suggests that once a logo has been paired repeatedly with a rewarding drink, the logo alone can capture attention and increase the… Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Neuropsychology, Ingestive Behavior
What is being tested?
3-week daily beverage intervention
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
176 participants
Where
No sites listed yet
Study dates
Mar 2027to May 2031
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Adults 18-45 years old
  • BMI = 18-34 kg/m2
  • Speak English fluently

Who cannot join

  • Current or past diagnosis of diabetes or metabolic disorder (thyroid disease, etc.)
  • Current or intended weight loss efforts (behavioral, GLP-1 agonists)
  • Gastric bypass or GLP-1 use in the previous 6 months
  • Current pregnancy or planning to become pregnant in the next 6 weeks
  • Claustrophobia (this would make lying in an MRI scanner very uncomfortable).
  • History of head injury resulting in loss of consciousness for more than 10 minutes
Show all 11Show fewer
  • Contraindications to MRI: Individuals with a pacemaker, aneurysm clips, neurostimulators, cochlear implants, metal in eyes, steel workers, or other implants.
  • History of diagnosed taste, smell, or eating disorders
  • History of alcohol or drug dependence
  • Active neurologic disorder
  • Food allergies or restrictive diet

About this study

Official title: Parsing the Impact of Calories Versus Sweet Taste on Beverage Brand Conditioning: A Randomized Controlled Trial

The purpose of this study is to learn how the sweet taste and the calorie content of a beverage affect the way people respond to the brand logo printed on that beverage. Previous work suggests that once a logo has been paired repeatedly with a rewarding drink, the logo alone can capture attention and increase the desire to consume. What is not yet known is whether the sweet taste, the calories, or both are responsible. Two current scientific explanations disagree on this point, and the study is designed to compare them. The investigators plan to enroll 176 healthy adults, 18 to 45 years old, with a body mass index between 18 and 34. People will not be eligible if they cannot safely have an MRI scan, are actively trying to lose weight or taking weight-loss medication, have a history of a taste, smell, or eating disorder, or have an active neurological condition.

Being tested
3-week daily beverage intervention
Keywords
sugar-sweetened beverage, fMRI, non-nutritive sweetener, neuropsychology, ingestive behavior
Medical subject headings
Feeding Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 3-week daily beverage interventionDietary supplement

    Beverage/brand condition with either sugar-sweetened beverage, nonnutritive sweetener, high-fructose corn syrup, or control.

Study groups in NCT07883096
Study groupRoleWhat they receive
Sugar-sweetened beverageExperimentalNot described
Receives: Dietary Supplement: 3-week daily beverage intervention
Nonnutritive SweetenerExperimentalNot described
Receives: Dietary Supplement: 3-week daily beverage intervention
High-fructose corn syrupExperimentalNot described
Receives: Dietary Supplement: 3-week daily beverage intervention
ControlNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stop Signal Task

    Measured: Completed during the pre- and post-intervention assessment visits scheduled at baseline and within 1-2 weeks of the 3-week long intervention.

  2. Body Composition

    Body Fat Mass, Lean Body Mass, Skeletal Muscle Mass, Total Body Water, all measured in kg

    Measured: Completed during the pre- and post-intervention assessment visits scheduled at baseline and within 1-2 weeks of the 3-week long intervention.

Secondary outcomes (5)
  1. Questionnaire

    Dutch Eating Questionnaire

    Measured: Completed during the pre- and post-intervention assessment visits scheduled at baseline and within 1-2 weeks of the 3-week long intervention.

  2. Questionnaire

    Barratt Impulsiveness Scale

    Measured: Completed during the pre- and post-intervention assessment visits scheduled at baseline and within 1-2 weeks of the 3-week long intervention.

  3. Questionnaire

    International Physical Activity Questionnaire

    Measured: Completed during the pre- and post-intervention assessment visits scheduled at baseline and within 1-2 weeks of the 3-week long intervention.

  4. Questionnaire

    Power of Food Scale

    Measured: Completed during the pre- and post-intervention assessment visits scheduled at baseline and within 1-2 weeks of the 3-week long intervention.

  5. Questionnaire

    Pittsburgh Sleep Quality Index

    Measured: Completed during the pre- and post-intervention assessment visits scheduled at baseline and within 1-2 weeks of the 3-week long intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Oct 2026
  2. Study startMar 2027 (estimated)
  3. Primary completionAug 2030 (estimated)
  4. Study completionMay 2031 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
176 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07883096
Sponsor's protocol ID
26-8069
Other IDs
1R01DK149422-01
Acronym
PSK
Status last verified
Oct 2026
First submitted
22 Sep 2026
Last updated
20 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing 3-week daily beverage intervention in people with Neuropsychology and Ingestive Behavior, run by Monell Chemical Senses Center.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 20 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stop Signal Task (time frame: Completed during the pre- and post-intervention assessment visits scheduled at baseline and within 1-2 weeks of the 3-week long intervention.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in